MK

Medha Kriti

Active Director Additional Director DIN 10897937
DIN 10897937 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Medha Kriti

Data last updated:

Medha Kriti is an Additional Director at Fls Pharma Private Limited (since 2025). The company operates in Paper.

DIN 10897937
Primary Designation Additional Director
Industry Paper
First Appointment 20 Jan 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fls Pharma Private Limited U21000JH2024PTC022782
Additional Director20 Jan 20252024Active

Board colleagues of Medha Kriti

NameDINCompanyDesignation
Afroze Khanam10898376Fls Pharma Private LimitedAdditional Director
Faizan Ahmad10659918Fls Pharma Private LimitedManaging Director
Nisha Rai10402591Fls Pharma Private LimitedAdditional Director
Tarique Asad10659917Fls Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fls Pharma Private Limited
Premium access

Shareholding and investment profile for Medha Kriti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medha Kriti

Medha Kriti currently holds 1 directorship: Fls Pharma Private Limited (Additional Director, since 20 Jan 2025).

Medha Kriti was first appointed on 20 Jan 2025 as Additional Director at Fls Pharma Private Limited.

The current boards of Medha Kriti's companies include Afroze Khanam (Fls Pharma Private Limited), Faizan Ahmad (Fls Pharma Private Limited), Nisha Rai (Fls Pharma Private Limited), Tarique Asad (Fls Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available